Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 4/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.38 |
| ▸ | KDM1A | O60341 | 4/20 | 0.37 |
| ▸ | MAOA | P21397 | 4/20 | 0.37 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7088611 | 0.81 | TSHR (0.45) | TSHRMAOBSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5371551 | 0.81 | TSHR (0.50) | TSHRHCRTR2HCRTR1KDM1AMAOA | |
| SCHEMBL7787343 | 0.81 | TSHR (0.50) | TSHRHCRTR2HCRTR1KDM1AMAOA | |
| SCHEMBL16377614 | 0.81 | TSHR (0.50) | TSHRHCRTR2HCRTR1KDM1AMAOA | |
| SCHEMBL9035063 | 0.80 | CYP2A6 (0.48) | CYP3A4TRPA1 | |
| SCHEMBL2943652 | 0.80 | HCRTR1 (0.40) | HCRTR2HCRTR1KDM1ASLC6A2SLC6A4 | |
| SCHEMBL2948970 | 0.79 | KMO (0.48) | HCRTR2HCRTR1KDM1AL3MBTL1 | |
| SCHEMBL22006623 | 0.78 | TSHR (0.42) | TSHRMAOBSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11507924 | 0.77 | TSHR (0.38) | TSHRKDM1AMAOAMAOBSLC6A2 | |
| SCHEMBL28642739 | 0.76 | HTR2B (0.37) | HCRTR2HCRTR1KDM1ASLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115666560-A | Methods and pharmaceutical compositions for treating thromboxane A2 receptor antagonists of COVID-19 | 马丁·奥格特树 | 2023-01-31 | — | — | CN | disclosed |
| US-20210226253-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2021-07-22 | — | — | US | disclosed |
| EP-0246195-A1 | Optically active iridium complexes and their use | CIBA-GEIGY AG (CH) | 1987-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210226253-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | TPO, DNASE1, KCNN2 | TSHR 1943/4885HCRTR2 2594/4885HCRTR1 1670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.